AmerisourceBergen Investors Pan Drug-Dregs Suit Report
An attorney for AmerisourceBergen stockholders challenged a single-member special litigation committee report recommending a Delaware vice chancellor dismiss their derivative damages claims over the company's unauthorized salvage and resale of cancer...To view the full article, register now.
Already a subscriber? Click here to view full article